Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

James Brockenbrough

Thoracic Surgery (Cardiothoracic Vascular Surgery) Kansas City, KS Medical Doctor

NPI 1932213139 CMS profile 1101640

21 N 12Th St Ste 103A, Kansas City, KS 66102

Open in the dashboard

General payments

$512

3 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, James Brockenbrough of Kansas City, KS is reported in the CMS Open Payments database as having received $512 across 3 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 18th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $21 1
2019 General $491 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Brockenbrough
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to James Brockenbrough were reported at $0. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year James Brockenbrough Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $491 $886 $178–$3,167 $163
2020 $21 $341 $108–$1,605 $114
2021 $0 $453 $125–$1,886 $132
2022 $0 $695 $180–$2,566 $149
2023 $0 $745 $205–$2,662 $160
2024 $0 $799 $214–$2,967 $164
2025 $0 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Musculoskeletal Transplant Foundation Inc. $491 2 payments
  2. Medline Industries, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Travel and Lodging $342 1 payment
  2. Food and Beverage $170 2 payments
Products named General payments · program years 2019–2020
  1. PluroGel Burn & Wound Dressings $21 1 payment
  2. Puracol Plus AG+ Collagen Dressings $21 1 payment
  3. Remedy Phytoplex Hydraguard $21 1 payment
  4. Remedy Protect Cloths $21 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

78

Prescriptions dispensed, refills included

Drug cost

$1,825

Paid at the pharmacy, in all

Branded share of claims

53.8%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $583
Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine Brand 11 $434
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $364
Oxycodone Hcl Generic 12 $257
Meloxicam Generic 11 $118
Donepezil Hcl Generic 13 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Records

3 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record